Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

0.9437 -0.0163 (-1.70%)
Streaming Delayed Price Updated: 1:26 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bionano Genomics Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
3 Contrarian Investments to Make Now for Massive Upside Potential
A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive. 
Via InvestorPlace
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript
BNGO earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023
BNGO stock results show that Bionano Genomics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
7 Penny Stocks to Buy on the Dip: February 2024
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks. 
Via InvestorPlace
Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings
These excellent contrarian stock picks are well-positioned to benefit from huge trends and are likely to be very profitable for investors. 
Via InvestorPlace
Bionano Genomics: Q3 Earnings Insights
Via Benzinga
A Preview Of Bionano Genomics's Earnings
Via Benzinga
What's Going On With Bionano Genomics Stock?
Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading lower Monday. The company's stock began trading on a reverse split-adjusted basis on Monday. 
Via Benzinga
Earnings Scheduled For March 5, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
Earnings Outlook For Bionano Genomics
Via Benzinga
How Is The Market Feeling About Bionano Genomics?
Via Benzinga
3 Stocks That Are Poised to Generate Outsized Returns
The Street is greatly underestimating the potential of these three names, making them wonderful stocks to buy for big returns. 
Via InvestorPlace
Bionano Genomics (BNGO) Q3 2023 Earnings Call Transcript
BNGO earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
3 Deeply Undervalued Growth Stocks
As in 2022, the current downturn of stocks appears to be way overdone, making this a good time to buy undervalued growth stocks. 
Via InvestorPlace
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks. 
Via InvestorPlace
The 3 Best High-Risk, High-Reward Stocks to Buy Now: September 2023
The stock market's multiple challenges should dissipate soon, making now a good time to buy high-risk, high-reward stocks. 
Via InvestorPlace
7 F-Rated Meme Stocks to Avoid Like the Plague
Meme stocks are rarely a good idea. These popular meme stocks should be avoided at all costs – no matter what you may see on social media. 
Via InvestorPlace
These Are the ONLY 3 Meme Stocks to Consider in August 2023
While all meme stocks have been crushed, there are still a few meme stocks that look poised to eventually succeed. 
Via InvestorPlace
Why Bionano Genomics Stock Tanked Today
A CFO departure shines a light on some of the company's recent struggles. 
Via The Motley Fool
3 Top Short Squeeze Stocks for August 2023
With the bears pouncing on many strong growth names, many excellent short squeeze opportunities have been created. 
Via InvestorPlace
Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript
BNGO earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
DKNG Stock Alert: Wells Fargo Just Upgraded DraftKings
DraftKings (DKNG) stock is on the move Monday after getting an upgrade and new price target from Wells Fargo analyst Daniel Politzer. 
Via InvestorPlace
SOVO Stock Alert: Campbell Soup Is Buying Sovos Brands for $2.7 Billion
Sovos Brands (SOVO) stock is rising higher on Monday following news that Campbell Soup (CPB) is acquiring the Italian sauces company. 
Via InvestorPlace
BNGO Stock Alert: Bionano Just Reverse Split Its Stock
Bionano was a hot genetic analysis stock two years ago but now needed a reverse split so that BNGO stock could stay listed on the Nasdaq. 
Via InvestorPlace
Looking for a Bargain? 3 Biotech Stocks to Buy That Are Down 20%-60% in 2023
Since the pharmaceutical sector is very lucrative in America, these biotech stock bargains can be very profitable. 
Via InvestorPlace
7 Doomed Growth Stocks Destined for Disaster
Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell. 
Via InvestorPlace
The 7 Best Growth Stocks to Buy in July
With the macro environment favorable and many companies reporting strong results, here are the seven best growth stocks to buy. 
Via InvestorPlace
3 Penny Stocks with Multibagger Potential for the Second Half of 2023
If you have patience and a high risk tolerance, here are three penny stocks to watch in 2023 for their multibagger potential. 
Via InvestorPlace
7 Healthcare Stocks to Make You the Millionaire Next Door
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy. 
Via InvestorPlace
Over $1M Bet On Bioventus? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.